2-[5-Amino-3-(4-chlorophenyl)pyrazol-1-yl]-3-benzylquinoxaline

ID: ALA3621364

PubChem CID: 101909244

Max Phase: Preclinical

Molecular Formula: C24H18ClN5

Molecular Weight: 411.90

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1cc(-c2ccc(Cl)cc2)nn1-c1nc2ccccc2nc1Cc1ccccc1

Standard InChI:  InChI=1S/C24H18ClN5/c25-18-12-10-17(11-13-18)21-15-23(26)30(29-21)24-22(14-16-6-2-1-3-7-16)27-19-8-4-5-9-20(19)28-24/h1-13,15H,14,26H2

Standard InChI Key:  JWHWJCGVBBDUFE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -1.2964    1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964   -1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9091   -1.5019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9067   -3.0027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2030   -3.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1976   -5.2575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8958   -6.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5995   -5.2481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6050   -3.7481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9086    1.5029    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0363    2.9847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5014    3.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2601    2.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2640    0.8910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1025    4.6816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3079    5.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0105    7.2733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5095    7.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3060    6.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6034    4.7311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0715    8.3877    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.5144   -0.2825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
  3 11  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 18 22  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 23 28  2  0
 26 29  1  0
 20 23  1  0
 22 30  1  0
  2 18  1  0
M  END

Associated Targets(Human)

NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-75 (44215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.90Molecular Weight (Monoisotopic): 411.1251AlogP: 5.31#Rotatable Bonds: 4
Polar Surface Area: 69.62Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.63CX LogP: 5.84CX LogD: 5.84
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -1.16

References

1. Issa DAE, Habib NS, Abdel Wahab AE.  (2015)  Design, synthesis and biological evaluation of novel 1,2,4-triazolo and 1,2,4-triazino[4,3-a]quinoxalines as potential anticancer and antimicrobial agents,  (1): [10.1039/C4MD00257A]

Source